ISPOR - EE508 Number Needed to Treat and Cost-per-Event Avoided for Dupilumab Versus Other Asthma Biologics for the Treatment of Moderate-to-Severe Asthma

Full Text

EE508 Number Needed to Treat and Cost-per-Event Avoided for Dupilumab Versus Other Asthma Biologics for the Treatment of Moderate-to-Severe Asthma

Abstract

Authors

F Joulain L Fourrier F Fanelli Z Wang WH Cheng

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now